OPTIMIZING MEDICATION RECONCILIATION AMONG OLDER ADULTS DURING COVID-19 INFECTION TREATMENT WITH PAXLOVID

COVID-19 infection treatment (CIT) has reframed optimizing medication reconciliation in older adults. In December 2021, FDA authorized Emergency Use Authorization of Paxlovid (Nirmatrelvir/Ritonavir), protease inhibitor blocking SARS-CoV-2 replication, to reduce severe COVID-19 and mortality in high...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, John, Browne, Tarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Late Breaking Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767184/
http://dx.doi.org/10.1093/geroni/igac059.2976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767184/
http://dx.doi.org/10.1093/geroni/igac059.2976

Ejemplares similares